Amlodipine Besylate NDC 71335-1865

Product information

Brand name (proprietary)

Amlodipine Besylate

Generic name (nonproprietary)

amlodipine besylate

Active ingredients

Amlodipine besylate — 10 mg/1

Dosage form

Tablet

Route

Oral

Labeler

Bryant Ranch Prepack

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 203245

Marketing start

May 22, 2019

Listing expires

Dec 31, 2026

Other FDA classes

Calcium Channel Antagonists (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)Dihydropyridines (Chemical structure)

Identifiers

Product ID 71335-1865_ef2eb5d8-d32f-4b45-af1d-5efd4b9ebfb2SPL ID ef2eb5d8-d32f-4b45-af1d-5efd4b9ebfb2SPL set ID b1151904-5085-49bd-94ec-cb2894f4eb10RxCUI 308135UNII 864V2Q084H

Pharmacologic class

Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335186500 followed by a unit qualifier and the quantity Copy

Package 71335-1865-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 203245

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

Showing 20 of 23.